The ATS 2015 International Conference will be May 15-20 in Denver.

Denver’s clean, thin air, and sunny climate were considered beneficial for those with tuberculosis, making it a destination for respiratory research early on. That history led to the development of medical institutions such as the University of Colorado, Aurora, the University of Colorado, Denver, and National Jewish Health, and their staffs of renowned researchers and clinicians.

It’s also what attracted Marvin I. Schwarz, MD, the James C. Campbell Professor of Pulmonary Medicine at the University of Colorado, Anschutz Medical Campus, Aurora, to the Denver area more than 40 years ago.

“There are long-standing collaborations between the institutions, and they have a history of academic leaders who have stayed in Denver or gone on to other medical schools,” says Dr. Schwarz, who led the University of Colorado program from 1985 to 2005 and has focused his research in pulmonary fibrosis and lung disease. “They are very active in clinical and basic research in COPD, asthma, lung cancer, and lung transplantation. Denver is very prominent in the history of medicine.”

The ATS 2015 International Conference in Denver, May 15-20, will carry on this great tradition by presenting the latest research in pulmonary, critical care, and sleep medicine. In addition to being surrounded by scientific and clinical discoveries during the conference, attendees will be in a region renowned for outdoor recreation, pro sports, and fine arts, with six neighborhood art districts, 20 museums, 100 art galleries, and the world-renowned Colorado Symphony Orchestra.

“Denver has a great convention center,” Dr. Schwarz says. “The hotels are very close, the downtown area is nice and safe to walk around, and there are a lot of good spots to eat.”

Planning is already under way, and all are encouraged to visit the ATS 2015 Call for Input webpage.